Back to Agenda
Risk Minimization Program Evaluation: How Can we Advance the Science?
Session Chair(s)
Meredith Yearsley Smith, MPA, FISPE
Fellow and faculty member, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States
This forum will explore the use of different evaluation designs and measurement approaches to advance the science of risk minimization program evaluation and include a recent case study to illustrate points.
Learning Objective : Define methodologic features of high-impact risk minimization program evaluation designs; Review existing risk evaluation and mitigation strategies (REMS) case studies and opportunities to improve their evaluation, including consideration of contextual factors and assessment of potential burden on the healthcare system; Describe how to improve the likelihood of publication of evaluation studies.
Speaker(s)
Almut G Winterstein, PHD, RPH, FISPE
Distinguished Professor, University of Florida, United States
Panelist
Giampiero Mazzaglia, MD, PHD, MSC
Associate Professor of Hygiene and Public Health, University of Milan, Italy
Panelist
Rachael L. DiSantostefano, PHD, MS
Senior Director, Epidemiology, Janssen Research & Development, LLC, United States
Panelist
Vincent Lo Re, MD, MS, FISPE
Associate Professor, U of Penn; Regional Editor of Americas, PDS, Pharmacoepidemiology and Drug Safety, United States
Panelist
Gianluca Trifiro, MD, PHD
Scientific Lead, INSPIRE; Professor, Pharmacology, Diagnostics and Public Health, University of Verona, Italy
Panelist
Have an account?